drugset / Trial / NCT02235298

Dapagliflozin Effects on Epicardial Fat

NCT02235298 ↗

Phase 4 Completed 100 enrolled University of Miami AstraZeneca · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this research study is to learn about the effect of Dapagliflozin (Farxiga) on the fat of the heart.

Timeline

Start
2015-09
Primary completion
2020-09-10
Completion
2020-09-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Dapagliflozin Small molecule 10 mg Oral
Background Metformin Small molecule 1000 mg Oral